drugset / Trial / NCT01406717
Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus
RandomizedParallel-groupQuadruple-blindTreatment
Summary
SPIL1033 resembles a gut hormone, which increases the insulin secretion, thus helps in reducing blood glucose levels. The purpose of study is to establish safety and efficacy of SPIL1033
Timeline
- Start
- 2013-03-01
- Primary completion
- 2015-11-04
- Completion
- 2015-11-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPIL1033 | Unknown | 10 ug | Subcutaneous |